Literature DB >> 19460127

Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants.

Charlotte Gimpel1, Alexandra Krause, Peter Franck, Marcus Krueger, Christian von Schnakenburg.   

Abstract

BACKGROUND: The objective of this study was to determine which of the many risk factors for nephrocalcinosis (NC) in preterm infants are most relevant.
METHODS: In 55 neonates born before 32 completed weeks of gestation, parameters relevant to NC were analyzed. Median birthweight was 1010 g (range 500-2070 g). Fifteen (27%) asymptomatic children had ultrasonographic NC.
RESULTS: In multivariate analysis the strongest independent risk factor was furosemide therapy above 10 mg per kg bodyweight cumulative dose, with a 48-fold increased risk of NC (odds ratio confidence interval 4.0-585, P < 0.01). The risk of NC was 1.65-fold higher per 100 g lower weight (1.07-2.56, P= 0.02) and 4.5-fold higher per mmol/l of urinary calcium concentration (1.14-17.7, P= 0.03). Many other risk factors were only significant in univariate analysis (gestational age, mechanical ventilation, infection, broncho-pulmonary dysplasia, blood transfusions, intraventricular hemorrhage, surfactant therapy, vasopressors, phenobarbital or caffeine, duration of hospital stay), indicating an indirect effect only. Other parameters of calcium and phosphate homeostasis were not significant, possibly due to standardized supplementation.
CONCLUSION: We suggest that in preterm infants, furosemide should be prescribed with caution and close monitoring of calcium excretions is advisable. Some guidelines for infant respiratory distress syndrome now favor calcium-sparing thiazides if diuretics are considered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460127     DOI: 10.1111/j.1442-200X.2009.02886.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  16 in total

Review 1.  Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.

Authors:  Audra Stewart; Luc P Brion
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

Review 2.  Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants.

Authors:  Gian Maria Pacifici
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

3.  Impact of Early Versus Late Diuretic Exposure on Metabolic Bone Disease and Growth in Premature Neonates.

Authors:  Lucas E Orth; Keliana L O'Mara
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Jan-Feb

4.  Renal function and kidney length in preterm infants with nephrocalcinosis: a longitudinal study.

Authors:  Vasileios Giapros; Constantina Tsoni; Anna Challa; Vasileios Cholevas; Maria Argyropoulou; Frederica Papadopoulou; Ekaterini Siomou; Aikaterini Drougia; Styliani Andronikou
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

Review 5.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

6.  Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural course.

Authors:  Jeanne Fayard; Pierre Pradat; Sylvie Lorthois; Justine Bacchetta; Jean-Charles Picaud
Journal:  Pediatr Nephrol       Date:  2022-03-28       Impact factor: 3.651

Review 7.  Drug-Induced Urolithiasis in Pediatric Patients.

Authors:  Maria Chiara Sighinolfi; Ahmed Eissa; Luigi Bevilacqua; Ahmed Zoeir; Silvia Ciarlariello; Elena Morini; Stefano Puliatti; Viviana Durante; Pier Luca Ceccarelli; Salvatore Micali; Giampaolo Bianchi; Bernardo Rocco
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

8.  Pamidronate as first-line treatment of hypercalcemia in neonatal subcutaneous fat necrosis: A case series.

Authors:  Alexander D Chesover; Jennifer Harrington; Farid H Mahmud
Journal:  Paediatr Child Health       Date:  2019-12-24       Impact factor: 2.253

9.  Prevention of vitamin D deficiency in children following cardiac surgery: study protocol for a randomized controlled trial.

Authors:  J Dayre McNally; Katie O'Hearn; Margaret L Lawson; Gyaandeo Maharajh; Pavel Geier; Hope Weiler; Stephanie Redpath; Lauralyn McIntyre; Dean Fergusson; Kusum Menon
Journal:  Trials       Date:  2015-09-09       Impact factor: 2.279

10.  Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge.

Authors:  Nicolas A Bamat; Timothy D Nelin; Eric C Eichenwald; Haresh Kirpalani; Matthew M Laughon; Wesley M Jackson; Erik A Jensen; Kathleen A Gibbs; Scott A Lorch
Journal:  J Pediatr       Date:  2020-11-03       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.